Plasma indomethacin assay using high-performance liquid chromatography- electrospray-tandem mass spectrometry: Application to therapeutic drug monitoring and pharmacokinetic studies

Therapeutic Drug Monitoring

Volumn 20, Issue 6, 1998, Pages 691-696

  Taylor, Paul J ^a   Jones, Christopher E ^a   Dodds, Helen M ^a   Hogan, Nicholas S ^a   Johnson, Anthony G ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

High performance liquid chromatography; Indomethacin; Pharmacokinetic studies; Tandem mass spectrometry; Therapeutic drug monitoring

Indexed keywords

ANTIINFLAMMATORY AGENT; INDOMETACIN; MEFENAMIC ACID; MEFIC; UNCLASSIFIED DRUG;

ACCURACY; ADULT; ANALYTIC METHOD; ARTICLE; CASE REPORT; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; INDOMETHACIN; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 0031784452     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199812000-00020     Document Type: Article

References (25)

1. Boardman PL, Hart DL. Side effects of indomethacin. Ann Rheum Dis 1976;26:127.
2. Berninger RW, Darsh DA, Fulton DR. The use of reversed phase cartridges (C18) in processing plasma for analysis of indomethacin by high performance liquid chromatography. J Clin Chem Clin Biochem 1986;24:227-32.
3. Tuckwell KR, Caswell A, Badewitz-Dodd LH, eds. MIMS annual. Singapore: Tien Wah Press, 1997:379-81.
4. Kwan KC, Breault GP, Umberhauer ER, et al. Kinetics of indomethacin absorption, elimination and enterohepatic circulation in man. J Pharmacokinet Biopharm 1976;4:255-80.
5. Gal P, Ransom JL, Weaver RL, et al. Indomethacin pharmacokinetics in neonates: The value of volume of distribution as a marker of permanent patent ductus arteriosus closure. Ther Drug Monit 1991;13:42-5.
6. Brown YL, Kandrotas RJ, Douglas JB, et al. High-performance liquid chromatographic determination of indomethacin serum concentrations. J Chromatogr 1988;459:275-9.
7. Brash AR, Hickey DE, Graham TP, et al. Pharmacokinetics of indomethacin in the neonate. New Engl J Med 1981;305:67-72.
8. Hare LE, Ditzler CA, Duggan DE. Radioimmunassay of indomethacin in biological fluids. J Pharm Sci 1977;66:486-2D9.
9. Johnson AG, Ray JE. Improved high-performance liquid chromatographic method for the determination of indomethacin in plasma. Ther Drug Monit 1992;14:61-5.
10. Guissou P, Cuisinaud G, Sassard J. Gas Chromatographic determination of indomethacin and its O-desmethylated metabolite in human plasma and urine. J Chromatogr 1983;277:368.
11. Singh AK, Jang Y, Mishra U, et al. Simultaneous analysis of flunixin, naproxen, ethacrynic acid, indomethacin, phenylbutazone, mefenamic acid and thiosalicylic acid in plasma and urine by high-performance liquid chromatography and gas chromatography-mass spectrometry. J Chromatogr 1991;568:351-61.
12. Cooper JK, McKay G, Hawes EM, et al. High-performance liquid chromatographic assay of indomethacin and its application in pharmacokinetics in healthy volunteers. J Chromatogr 1982;233:289-96.
13. Roberts I, Smith IM. A high performance liquid chromatography method for the analysis of total and free indomethacin in serum. Ann Clin Biochem 1987;24:167-71.
14. Al-Angary AA, El-Sayed YM, Al-Meshal MA, et al. High-performance liquid chromatographic analysis of indomethacin in serum. J Clin Pharm Ther 1990;15:257-65.
15. Bruins AP. Atmospheric-pressure-ionisation mass spectrometry. Trends in Anal Chem 1994;13:37-43.
16. Taylor PJ, Jones A, Balderson GA, et al. Sensitive, specific quantitative analysis of tacrolimus (FK506) in blood by liquid chromatography-electrospray tandem mass spectrometry. Clin Chem 1996;42:279-85.
17. Fredline VF, Taylor PJ, Dodds HM, et al. A reference method for the analysis of aldosterone in blood by high-performance liquid chromatography-atmospheric chemical ionisation-tandem mass spectrometry. Anal Biochem 1997;252:308-13.
18. Morden W, Wilson ID. The detection and characterisation of analgesics and anti-inflammatory drugs on high performance thin-layer chromatography: application to drugs and metabolites in urine. Rapid Commun Mass Spectrom 1996;10:1951-5.
19. Dawson M, Smith MD, McGee CM. Gas chromatography/negative ion chemical ionisation/tandem mass spectrometric quantification of indomethacin in plasma and synovial fluid. Biomed Environ Mass Spectrom 1990;19:453-8.
20. Krouwer JS, Rabinowtz R. How to improve estimates of imprecision. Clin Chem 1984;30:290.
21. Shah VP, Midha KK, Dighe S, et al. Analytical methods validation: Bioavailability, bioequivalence, and pharmacokinetic studies. J Pharm Sci 1992;8:309-12.
22. Whitman DA, Abbott V, Freigien K, et al. Recent advances in high-performance liquid chromatography/mass spectrometry and high-performance liquid chromatography/tandem mass spectrometry: Detection of cyclosporine and metabolites in kidney and liver tissue. Ther Drug Monit 1993;15:552-6.
23. Taylor PJ, Hogan NS, Lynch SV, et al. Improved therapeutic drug monitoring of tacrolimus (FK 506) by tandem mass spectrometry. Clin Chem 1997;43:2189-90.
24. Neander G, Eriksson LO, Wallin-Boll E, et al. Pharmacokinetics of intraarticular indomethacin in patients with osteoarthritis. Eur J Clin Pharmacol 1992;42:301-5.
25. Bruguerolle B, Barbeau G, Belanger PM, et al. Pharmacokinetics of a sustained-release product of indomethacin in the elderly. Gerontology 1986;32:277-85.